Canada markets open in 8 hours 54 minutes

Astellas Pharma Inc. (4503.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
Add to watchlist
1,558.00+33.00 (+2.16%)
At close: 03:15PM JST
Currency in JPY

Valuation Measures4

Market Cap (intraday) 2.79T
Enterprise Value 3.38T
Trailing P/E 587.92
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.82
Price/Book (mrq)1.86
Enterprise Value/Revenue 2.19
Enterprise Value/EBITDA 20.13

Trading Information

Stock Price History

Beta (5Y Monthly) 0.29
52-Week Change 3-24.70%
S&P500 52-Week Change 322.38%
52 Week High 32,360.50
52 Week Low 31,426.00
50-Day Moving Average 31,590.60
200-Day Moving Average 31,830.67

Share Statistics

Avg Vol (3 month) 39.07M
Avg Vol (10 day) 39.05M
Shares Outstanding 51.79B
Implied Shares Outstanding 61.81B
Float 81.79B
% Held by Insiders 10.25%
% Held by Institutions 150.98%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 474
Forward Annual Dividend Yield 44.75%
Trailing Annual Dividend Rate 370.00
Trailing Annual Dividend Yield 34.59%
5 Year Average Dividend Yield 42.68
Payout Ratio 42,452.83%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 27, 2024
Last Split Factor 25:1
Last Split Date 3Mar 27, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 1.06%
Operating Margin (ttm)-7.98%

Management Effectiveness

Return on Assets (ttm)1.80%
Return on Equity (ttm)1.10%

Income Statement

Revenue (ttm)1.6T
Revenue Per Share (ttm)894.27
Quarterly Revenue Growth (yoy)17.00%
Gross Profit (ttm)N/A
EBITDA 244.7B
Net Income Avi to Common (ttm)17.05B
Diluted EPS (ttm)2.65
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)335.69B
Total Cash Per Share (mrq)187.23
Total Debt (mrq)920.02B
Total Debt/Equity (mrq)57.65%
Current Ratio (mrq)0.93
Book Value Per Share (mrq)890.18

Cash Flow Statement

Operating Cash Flow (ttm)172.48B
Levered Free Cash Flow (ttm)109.61B